Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 72 | 15 | 7 | 0 |
| Receivables | 3 | N/A | N/A | N/A | 0 |
| TOTAL | $12 | $118 | $64 | $65 | $0 |
| Non-Current Assets | |||||
| PPE Net | 69 | 95 | 331 | 412 | N/A |
| Intangibles | 3 | 3 | 3 | 4 | 0 |
| Other Non-Current Assets | 4 | 5 | 4 | 4 | 0 |
| TOTAL | $77 | $103 | $339 | $420 | $N/A |
| Total Assets | $88 | $221 | $403 | $486 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 739 | 426 | 658 | 309 | 0 |
| Accrued Expenses | 615 | 440 | 754 | 578 | 0 |
| TOTAL | $4,414 | $3,907 | $3,747 | $2,814 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 154 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $154 | $N/A |
| Total Liabilities | $4,414 | $3,907 | $3,747 | $2,968 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 205 | 194 | 181 | 170 | N/A |
| Common Shares | 656 | 636 | 603 | 585 | 0 |
| Retained earnings | -9,019 | -7,525 | -6,782 | -5,769 | 0 |
| Other shareholders' equity | -32 | -32 | -32 | -32 | 0 |
| TOTAL | $-4,326 | $-3,686 | $-3,344 | $-2,483 | $0 |
| Total Liabilities And Equity | $88 | $221 | $403 | $486 | $0 |